Else Nutrition Holdings Inc (OTCQX:BABYF, TSX-V:BABY) has announced highly favorable results from an independent pilot study conducted with US mom customers of its Plant-Based Nutrition for Toddlers and Kids.
Conducted independently by third party global market research firm, GetWizer, the study revealed over three-quarters of parents whose children suffered from gastrointestinal problems (vomiting, reflux, spit ups) whilst using another formula or supplement, reported these symptoms improved after using Else Toddler or Else Kids.
“These results are extremely encouraging and provide independent validation as to the potentially significant difference clean label, whole plant food-based Else products are making with children across the country,” said Hamutal Yitzhak, CEO and co-founder of Else Nutrition in a statement.
“Improving lives and providing a real alternative to dairy for early childhood nutrition was the spark for starting Else and it is reassuring to see validation from moms that Else products are truly helping to make their families’ lives better,” she added.
READ: Else Nutrition updates on key sales growth drivers for 2022
The pilot study revealed major improvement in disorders and symptoms related to feeding problems such as:
- Weight gain – poor weight gain and growth problem was resolved in over 82% of the cases
- GI related symptoms (spit up, vomit, etc) – were improved in over 85% and about half of them reported significant to 100% complete improvement
- Bowel movements were improved in over 79% of the cases and almost 100% reported change in stool consistency from too hard or too loose to a more “normal” stool
- Rash symptoms were improved in over 86% (improvement was reported in severity, frequency and length of symptoms)
The pilot study indicated that top reported reasons for starting the child on Else Drink were: 1. Plant-Based diet or healthy lifestyle; 2. Else products natural ingredients; 3. To help address a clinical condition (i.e. food sensitivities, allergies, etc.)
Additionally, it said, 75% chose Else based on plant-based/healthy lifestyle and preferred ingredients and 25% to address medical reasons such as poor growth, intolerances and allergies, Over 70% of the kids loved the taste and are happy and enjoy drinking it and 97% of parents intend to continue giving their child Else nutritional products. Of those surveyed, 90% of parents said they would recommend using Else products to their friends
The GetWizer pilot study was independently conducted via electronic, online survey among randomly selected customers using Else Plant-Based Nutrition for Toddlers and Kids. The survey will now be expanded to more mothers to ensure a larger sample size, the company said.
Amazon expansion
Else Nutrition also said, separately, that following its stellar success on Amazon in the US, the company was recently invited by Amazon EU to launch a European unified account.
This will allow Else to sell its unique products on all of Amazon European marketplaces including the UK, Germany, France, Italy, Spain, the Netherland, and Sweden representing a market with over 300 million people.
Else said it has already started the onboarding process with Amazon’s support and plans to launch its first European market in early 2022.
“We’re very excited by this opportunity offered by Amazon EU. Amazon has been a fantastic go-to-market channel for us in the US, and we expect it to perform well also in Europe and in other countries, such as Canada, said Else Nutrition CEO & co-founder Yitzhak.
Final approval for Toronto Stock Exchange listing
And in another separate statement on Thursday, Else Nutrition also said it has received conditional approval to list its common shares and warrants on the Toronto Stock Exchange (TSX).
Final approval is subject to the company meeting certain customary conditions of the TSX on or before January 20, 2022. At that time, Else’s common shares and warrants will be concurrently delisted from the TSX Venture Exchange. The trading symbol for the common shares and warrants of the company on TSX will remain unchanged as BABY.
“This is a significant milestone for the Company. We believe the graduation to the TSX, one of the premier exchanges for publicly traded companies, will broaden our reach among institutional investors and improve our access to the capital markets," commented Else Nutrition CEO & co-founder Yitzhak.
“Else is at an exciting point in its growth and we are excited to have been elevated to the TSX and look forward to sharing our story and growth strategy with a new audience of international investors," she added.
Else Nutrition is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula.
The company (formerly INDI) won the '2017 Best Health and Diet Solutions' award at the Global Food Innovation Summit in Milan. Else Plant-Based Complete Nutrition for Toddlers was recently ranked as the #1 Top seller in the baby and toddler formula category on Amazon.
Else's executives include leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children's Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children's Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.
Contact the author at jon.hopkins@proactiveinvestors.com